Radiation Oncology Program

ASTRO 2008 Presentations

The American Society for Therapeutic Radiology and Oncology
50th Annual Meeting
September 21-25, 2008
Boston, MA

UMGCC's Department of Radiation Oncology will present the following sessions at the 2008 ASTRO meeting.

 

Sunday, September 21st, 2008
Time: 4:15 p.m. – 5:45 p.m.
Topic: The Current Role of Tri-Modality Therapy in Stage III Non-Small Cell Lung Cancer
Education Session: 104
Panel 01  
Moderator: Mohan Suntharalingam, M.D.

top


Tuesday, September 23rd , 2008
Time: 11:00 a.m. – 12:30 p.m.
Session Name: SSL: PHYSICS II
Topic: Treatment Room Imaging 1: Clinical Applications
Presenter: Jianzhou Wu

top

Wednesday, September 24th, 2008
Time: 10:15 – 11:45 a.m.
Session Name: SSS: GUII
Topic: Long-term Results of a Prospective Phase II Trial of Androgen Ablation, Pelvic External Beam Radiation Therapy, Brachytherapy Boost, and Adjuvant Docetaxel in High-risk Prostate Cancer
Presenter: Young Kwok, M.D.
 
Time: 10:15 – 11:45 a.m.
Session Name: Scientific Session R
Topic: Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: An RTOG Consensus Panel Contouring Atlas
Co-Presenter: Michael Garofalo, M.D.
 
Time: 1:00 – 2:30 p.m.
Session Name: GU III Long Term Trial Results
Topic: Analysis of Late Toxicity of a Phase I/II Trial of Weekly Paclitaxel, Concurrent Radiation (RT) and Androgen Ablation (AA) in Locally Advanced Prostate Cancer (LAPC) or after Radical Prostatectomy (RP)
Presenter: Ali Mirmiran, M.D.

top

Staff Posters

Abstract Titles:

Radiation Therapy (RT) as a Chemopotentiator of Gemcitabine (G) in Patients with Advanced Pancreatic Cancer: A Multi-institutional Phase II Study.
William Regine, M.D.

A Comparison of 3D-CRT and IMRT Planning for Patients with T3Nx or T4Nx Mid/Distal Rectal Cancers: Potential for Small Bowel Sparing and Reductions in Dose-limiting Acute GI Toxicity.
Michael Garofalo, M.D.

Is Weekly Megavoltage Image Verification Necessary after Daily kV Image Guidance?
Byong Yong Yi, Ph.D., Fritz Lerma, Ph.D., Mohan Suntharalingam, M.D.

Dosimetric Analysis of the Effect of Prostate Edema on Cs-131 Brachytherapy.
Usama Mahmood, M.D.

Can an early-stage NSCLC tumor be defined from a free-breathing PET scan for SBRT planning?
Anil Dhople, M.D., Fritz Lerma, Ph.D., Byong Yong Yi, Ph.D.

High-Dose Spatially-Fractionated Radiation Therapy (SFGRT): A Comparison of Outcomes of Treatment Delivered Through Cerrobend GRID versus MLC GRID
Geoffrey Neuner, M.D.

Image-Guided Intermediate-Stage Prostate Cancer IMRT: Minimum Margins and an Ideal Alignment Strategy
Fritz Lerma, Ph.D.

Intensity-Modulated Radiation Therapy (IMRT) Significantly Improves Acute Gastrointestinal Toxicity in Pancreatic and Ampullary Cancers: A Multi-Institutional Experience
Susannah Yovino, M.D.

The Impact of Neo-adjuvant Treatment on Survival in Stage III Non-small Cell Lung Cancer (NSCLC): Results from the SEER Registration
Matthew Koshy, M.D.

Volumetric Image-guidance: Does Routine Usage Prompt Adaptive Re-Planning?
Warren D’Souza, Ph.D.

Respiratory Liver Tumor Motion Reduction Using An Abdominal Arc Compression Device.
Warren D’Souza, Ph.D.

Optimal Beam Arrangement for Stereotactic Body Radiation Therapy of Lung Lesions: RTOG 0236 criteria.
Anil Dhople, M.D., Warren D’Souza, Ph.D., Ali Mirmiran, M.D., Byong Yong Yi, Ph.D.

Dose-delivery Conformation of SBRT of the Head of Pancreas Cancer, Using a Non-Rigid Image Registration
Fritz Lerma, Ph.D., Michael Garofalo, M.D.

top


This page was last updated on: September 15, 2008.

For More Information